Mexico approves emergency use for Pfizer pill against COVID-19

Stock image. Paxlovid, a Pfizer coronavirus disease (COVID-19) pill, is manufactured in Ascoli, Italy, in this undated photo obtained by Reuters. November 16, 2021. REUTERS/Pfizer

MEXICO CITY, Jan 14 (Reuters) – Mexico’s health regulator announced on Friday the authorization for emergency use of pharmaceutical company Pfizer’s Paxlovid pill to treat adult patients with mild or moderate COVID-19.

In early December, the Mexican authorities already endorsed a combination of two injectable drugs from the pharmaceutical company Eli Lilly and Company to care for patients with the disease caused by the coronavirus.

Paxlovid has already received authorization in several countries. At the end of December from the Food and Drug Administration of the United States (FDA, for its acronym in English) and the health agency of the United Kingdom, MHRA.

Mexico has already exceeded 300,000 deaths from coronavirus and is immersed in a fourth wave of infections, now driven by the omicron variant, while the Government continues to vaccinate its population.

(Reporting by Adriana Barrera)

Leave a Reply

Your email address will not be published.